These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17882158)

  • 1. Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain.
    Kowalski KG; Olson S; Remmers AE; Hutmacher MM
    Clin Pharmacol Ther; 2008 Jun; 83(6):857-66. PubMed ID: 17882158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R; Krishnaswami S; Kowalski K
    Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor valdecoxib.
    Schachtel BP; Pan S; Kohles JD; Sanner KM; Schachtel EP; Bey M
    J Clin Pharmacol; 2007 Jul; 47(7):860-70. PubMed ID: 17525166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.
    Ushiyama S; Yamada T; Murakami Y; Kumakura S; Inoue S; Suzuki K; Nakao A; Kawara A; Kimura T
    Eur J Pharmacol; 2008 Jan; 578(1):76-86. PubMed ID: 17920584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
    Lee IO; Seo Y
    Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors.
    Huntjens DR; Spalding DJ; Danhof M; Della Pasqua OE
    Eur J Pain; 2009 May; 13(5):448-57. PubMed ID: 18774319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic modeling of renin biomarkers in subjects treated with the renin inhibitor aliskiren.
    Hong Y; Dingemanse J; Mager DE
    Clin Pharmacol Ther; 2008 Jul; 84(1):136-43. PubMed ID: 18288088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective dose of valdecoxib in experimental mouse models of pain.
    Guo CX; Irwin MG; Cheung KM; Chan D
    Methods Find Exp Clin Pharmacol; 2007; 29(6):383-8. PubMed ID: 17922065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
    Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
    Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
    Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
    Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data.
    Schug SA; Joshi GP; Camu F; Pan S; Cheung R
    Anesth Analg; 2009 Jan; 108(1):299-307. PubMed ID: 19095866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.
    Erdélyi P; Fodor T; Varga AK; Czugler M; Gere A; Fischer J
    Bioorg Med Chem; 2008 May; 16(9):5322-30. PubMed ID: 18353655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PK/PD modelling and simulations: utility in drug development.
    Rajman I
    Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial.
    Kollenz C; Phleps W; Kaehler ST
    Gynecol Obstet Invest; 2009; 67(1):25-31. PubMed ID: 18824862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of parecoxib on postoperative pain after lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial.
    Jirarattanaphochai K; Thienthong S; Sriraj W; Jung S; Pulnitiporn A; Lertsinudom S; Foocharoen T
    Spine (Phila Pa 1976); 2008 Jan; 33(2):132-9. PubMed ID: 18197096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib.
    Giraudel JM; King JN; Jeunesse EC; Lees P; Toutain PL
    J Vet Pharmacol Ther; 2009 Feb; 32(1):18-30. PubMed ID: 19161452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.